Faecal microbiota transplantation: a review of FMT as an alternative treatment forClostridium difficileinfection
Author:
Open Access
- 22 September 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Bioscience Horizons
- Vol. 9
Abstract
Clostridium difficile infection (CDI) is the most common aetiology of hospital acquired infections, the leading cause of nosocomial diarrhoea and a significant clinical and economic burden. Recommended treatment for CDI is prescription of broad-spectrum antibiotics. Antibiotic treatment disrupts natural gut microbiota allowing C. difficile to colonize. Clostridium difficile is also resistant to antibiotics and may persist in the gastrointestinal tract for months causing recurrent disease. There is a pressing need for alternate therapies. Faecal microbiota transplantation (FMT) is a promising treatment option whereby healthy donor faecal samples are infused into a patient thus, theoretically, restoring normal bowel conditions. Until recently there has been a paucity of randomized controlled trials and reports of FMT efficacy have been limited to case studies and series. Here, a meta-analysis of 684 patients treated with FMT across 23 independent studies was conducted, reporting a mean resolution rate of 90.4%. Three RCTs are included that, although methodologically limited, appear to verify reports of high efficacy in case reports with minimal adverse effects. FMT appears to be a safe, highly efficacious and affordable treatment option. Future research should focus on potential long-term safety concerns and optimizing protocols for donor screening, patient selection and FMT administration.Keywords
This publication has 59 references indexed in Scilit:
- Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infectionAlimentary Pharmacology & Therapeutics, 2015
- Weight Gain After Fecal Microbiota TransplantationOpen Forum Infectious Diseases, 2015
- American Journal of Gastroenterology Lecture: Intestinal Microbiota and the Role of Fecal Microbiota Transplant (FMT) in Treatment of C. difficile InfectionAmerican Journal of Gastroenterology, 2013
- Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile InfectionAmerican Journal of Gastroenterology, 2012
- Fecal microbiota transplantation and emerging applicationsNature Reviews Gastroenterology & Hepatology, 2011
- Treating Clostridium difficile Infection With Fecal Microbiota TransplantationClinical Gastroenterology and Hepatology, 2011
- Clostridium difficile infection in Europe: a hospital-based surveyThe Lancet, 2011
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infection Control & Hospital Epidemiology, 2010
- Case reports and case series from had significant impact on medical literatureJournal of Clinical Epidemiology, 2005
- RecurrentClostridium difficileColitis: Case Series Involving 18 Patients Treated with Donor Stool Administered via a Nasogastric TubeClinical Infectious Diseases, 2003